
NYSEHealthcareMedical - Pharmaceuticals
أحدث البيانات المتاحة
48.23 US$
+0.36 US$ · +0.75%
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
الإغلاق السابق
48.23 US$
+0.36 US$ · +0.75%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
نطاق اليوم
السعر الحالي 48.23 US$
نطاق 52 أسبوعًا
السعر الحالي 48.23 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
83
قيمة جذابة جدًا
المشاعر
52
مختلط
المخاطر
42
مخاطر أعلى من المعتاد
الزخم
30
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
نطاق اليوم
السعر الحالي 48.23 US$
نطاق 52 أسبوعًا
السعر الحالي 48.23 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 1.09 مليار USD | 1.14 مليار USD | 1.13 مليار USD | 1.13 مليار USD | 1.09 مليار USD |
| تكلفة البضاعة المباعة | 514.07 مليون USD | 503.3 مليون USD | 500.91 مليون USD | 502.43 مليون USD | 466.17 مليون USD |
| الربح الإجمالي | 574.64 مليون USD | 634.46 مليون USD | 624.45 مليون USD | 625.29 مليون USD | 620.65 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 265.23 مليون USD | 263.93 مليون USD | 259.47 مليون USD | 252.42 مليون USD | 264.8 مليون USD |
| نفقات التشغيل | 265.23 مليون USD | 297.69 مليون USD | 282.02 مليون USD | 647.71 مليون USD | 290.73 مليون USD |
| مصاريف الفوائد | 42.34 مليون USD | 47.63 مليون USD | 67.16 مليون USD | 69.16 مليون USD | 64.29 مليون USD |
| الاستهلاك والإطفاء | 31.27 مليون USD | 30.17 مليون USD | 30.68 مليون USD | 32.63 مليون USD | 32.09 مليون USD |
| الدخل التشغيلي | 309.41 مليون USD | 336.78 مليون USD | 342.43 مليون USD | −22.42 مليون USD | 329.92 مليون USD |
| صافي الدخل | 190.3 مليون USD | 214.61 مليون USD | 209.34 مليون USD | −82.31 مليون USD | 205.38 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Core S&P Small-Cap ETFIJR135.41 مليون0.13%103.19 مليار USD0.06%137.55 US$+0.17%
Vanguard Morningstar Total Stock Market ETFVTI78.47 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM60.19 مليون0.08%78.74 مليار USD0.19%278.94 US$+0.49%
Vanguard Morningstar Small-Cap ETFVB56.36 مليون0.03%185.3 مليار USD0.03%289.48 US$+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV39.75 مليون0.15%26.81 مليار USD0.33%37.95 US$-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR35.84 مليون0.05%68.2 مليار USD0.05%234.43 US$+0.22%
Vanguard Extended Market ETFVXF28.47 مليون0.03%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Targeted Value ETFDFAT21.11 مليون0.07%30.12 مليار USD0.33%67.27 US$-0.43%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.